Literature DB >> 26377864

Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.

Derek F J Brown1, Mandy Wootton2, Robin A Howe2.   

Abstract

The BSAC Standing Committee on Antimicrobial Susceptibility Testing is one of several European national breakpoint committees that agreed in 2002 to harmonize clinical MIC breakpoints. The process of harmonization has since been completed for commonly used agents, and breakpoints for new agents have been set by EUCAST in accordance with a procedure defined by the EMA. EUCAST breakpoints have now been adopted by a large majority of laboratories in Europe. BSAC implemented the EUCAST breakpoints in its own disc diffusion susceptibility testing method as harmonized breakpoints were agreed to over the years. Since the development of the EUCAST disc diffusion method, several countries with their own disc diffusion methods have switched to the EUCAST method, and BSAC will replace support of its own disc diffusion method with support for the EUCAST method from January 2016. The EUCAST breakpoints are also available in automated systems. The harmonized breakpoints and methods will help to avoid different reports of susceptibility for the same isolate in different countries and enable more reliable comparison of resistance rates in surveillance studies in different countries.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Mesh:

Substances:

Year:  2015        PMID: 26377864     DOI: 10.1093/jac/dkv287

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

Review 1.  MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: current achievements and future perspectives.

Authors:  Georgia Vrioni; Constantinos Tsiamis; George Oikonomidis; Kalliopi Theodoridou; Violeta Kapsimali; Athanasios Tsakris
Journal:  Ann Transl Med       Date:  2018-06

2.  Amino Acid Biosynthetic Pathways Are Required for Klebsiella pneumoniae Growth in Immunocompromised Lungs and Are Druggable Targets during Infection.

Authors:  Rebecca J Silver; Michelle K Paczosa; Anne L McCabe; Joan-Miquel Balada-Llasat; James D Baleja; Joan Mecsas
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Antimicrobial stewardship: can we add pharmacovigilance networks to the toolbox?

Authors:  Jean Marie Vianney Habarugira; Albert Figueras
Journal:  Eur J Clin Pharmacol       Date:  2020-11-16       Impact factor: 2.953

4.  The impact of DNA adenine methyltransferase knockout on the development of triclosan resistance and antibiotic cross-resistance in Escherichia coli.

Authors:  Lewis Hughes; Wayne Roberts; Donna Johnson
Journal:  Access Microbiol       Date:  2020-11-18

Review 5.  Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics.

Authors:  Callum J Cooper; Mohammadali Khan Mirzaei; Anders S Nilsson
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

6.  Prevalence and Antimicrobial Resistance Pattern of Salmonella, Shigella, and Intestinal Parasites and Associated Factor among Food Handlers in Dilla University Student Cafeteria, Dilla, Ethiopia.

Authors:  Kuma Diriba; Ephrem Awulachew; Zemach Ashuro
Journal:  Int J Microbiol       Date:  2020-05-27

7.  Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014-2015.

Authors:  Anne Santerre Henriksen; Jennifer I Smart; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2018-08-28       Impact factor: 4.003

8.  Antibiotic Resistance of Commensal Staphylococcus aureus and Coagulase-Negative Staphylococci in an International Cohort of Surgeons: A Prospective Point-Prevalence Study.

Authors:  Mario Morgenstern; Christoph Erichsen; Simon Hackl; Julia Mily; Matthias Militz; Jan Friederichs; Sven Hungerer; Volker Bühren; T Fintan Moriarty; Virginia Post; R Geoff Richards; Stephen L Kates
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

Review 9.  Identification and Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Rubik's Cube of Clinical Microbiology?

Authors:  Márió Gajdács; Gabriella Spengler; Edit Urbán
Journal:  Antibiotics (Basel)       Date:  2017-11-07

Review 10.  Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.

Authors:  Derry K Mercer; Marcelo D T Torres; Searle S Duay; Emma Lovie; Laura Simpson; Maren von Köckritz-Blickwede; Cesar de la Fuente-Nunez; Deborah A O'Neil; Alfredo M Angeles-Boza
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.